Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote NLRP3‑dependent pyroptosis in non‑small cell lung cancer cells

Xi,Yunzhu; Zeng,Saili; Tan,Xiaowu; Deng,Xiaoyu

doi:10.3892/ijo.2025.5727

Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote NLRP3‑dependent pyroptosis in non‑small cell lung cancer cells

Authors:
- Yunzhu Xi
- Saili Zeng
- Xiaowu Tan
- Xiaoyu Deng
View Affiliations

Affiliations: Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital, University of South China, Hengyang, Hunan 421000, P.R. China
Published online on: February 13, 2025 https://doi.org/10.3892/ijo.2025.5727
Article Number: 21
Copyright: © Xi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑small cell lung cancer (NSCLC) is a malignant tumor of significant clinical relevance. Curcumin has been investigated for its potential anticancer properties, as it has been reported to act through multiple cancer‑related targets and pathways. The present study aimed to explore the effects of curcumin in NSCLC using both in vitro and in vivo models. NSCLC cell lines (specifically, A549 and NCI‑H1299 cells), and a mouse tumor model established through the subcutaneous injection of A549 cells, were utilized to evaluate the effects of curcumin intervention. The effects of treatment with curcumin on NOD‑like receptor pyrin domain‑containing 3 (NLRP3) ubiquitination, cell pyroptosis and pyroptosis‑associated factors were also evaluated. In addition, Smad ubiquitination regulatory factor 2 (Smurf2) was analyzed via a series of knockdown and overexpression experiments, both in vitro and in vivo, aimed at investigating its association with curcumin and NLRP3. The results obtained from these experiments showed that curcumin inhibited NSCLC cell growth, promoted pyroptosis and reduced the level of NLRP3 ubiquitination. NLRP3 knockdown reversed the curcumin‑induced increase in pyroptosis‑associated factors both in vitro and in vivo. Additionally, Smurf2 interacted with NLRP3 and alterations in Smurf2 expression levels influenced NLRP3 ubiquitination and cell pyroptosis. Moreover, molecular docking analysis demonstrated that curcumin could bind directly to Smurf2, which subsequently led to an inhibition of Smurf2 activity. Knockdown of Smurf2 enhanced curcumin's ability to stabilize NLRP3 and to promote pyroptosis, whereas Smurf2 overexpression negated these effects. In the in vivo animal model, curcumin treatment led to reduced tumor volumes and weights, in addition to a decreased expression level of Ki67 and increased expression levels of NLRP3 and pyroptosis‑associated factors. Similarly, these effects were enhanced or reversed by Smurf2 knockdown or overexpression, respectively. In conclusion, the findings of the present study showed that curcumin inhibited Smurf2 activity, thereby promoting NLRP3‑dependent pyroptosis in NSCLC cells. In addition, these findings have provided mechanistic insights into the role of curcumin in NSCLC, opening an avenue for its potential therapeutic application.

View Figures

View References

1	Srivastava S, Mohanty A, Nam A, Singhal S and Salgia R: Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics. Semin Cancer Biol. 86:233–246. 2022. View Article : Google Scholar : PubMed/NCBI
2	Ganti AK, Klein AB, Cotarla I, Seal B and Chou E: Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US. JAMA Oncol. 7:1824–1832. 2021. View Article : Google Scholar : PubMed/NCBI
3	Clark SB and Alsubait S: Non-small cell lung cancer. StatPearls. StatPearls Publishing LLC; Treasure Island, FL: 2024
4	Jonna S and Subramaniam DS: Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): An update. Discov Med. 27:167–170. 2019.
5	Huang X, Wang Y, Yang W, Dong J and Li L: Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment. Front Nutr. 9:9748962022. View Article : Google Scholar : PubMed/NCBI
6	Kotha RR and Luthria DL: Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. 24:29302019. View Article : Google Scholar : PubMed/NCBI
7	Wan Mohd Tajuddin WNB, Lajis NH, Abas F, Othman I and Naidu R: Mechanistic understanding of curcumin's therapeutic effects in lung cancer. Nutrients. 11:29892019. View Article : Google Scholar : PubMed/NCBI
8	Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y, Yu T, Wu X, Shi Y, Ma P and Shu Y: Pyroptosis: A new frontier in cancer. Biomed Pharmacother. 121:1095952020. View Article : Google Scholar
9	Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, Liu W, Deng H, Li J, Ning P and Wang Z: Pyroptosis in inflammatory diseases and cancer. Theranostics. 12:4310–4329. 2022. View Article : Google Scholar : PubMed/NCBI
10	Guo J, Yan W, Duan H, Wang D, Zhou Y, Feng D, Zheng Y, Zhou S, Liu G and Qin X: Therapeutic effects of natural products on liver cancer and their potential mechanisms. Nutrients. 16:16422024. View Article : Google Scholar : PubMed/NCBI
11	Yuan R, Zhao W, Wang QQ, He J, Han S, Gao H, Feng Y and Yang S: Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis. Pharmacol Res. 170:1057482021. View Article : Google Scholar : PubMed/NCBI
12	Duan H, Jiang L, Sun X, Liu X, Yang G, Sun X, Cheng T, Ji Y, Zhang F, Du Y, et al: Curcumin induces MCF-7 cells pyroptosis via autophagy/CTSB/NLRP3/caspase-1/GSDMD signaling pathway in vitro and vivo. J Vet Heal Sci. 3:250–261. 2022.
13	Feng SH, Zhao B, Zhan X, Li RH, Yang Q, Wang SM and Li A: Quercetin-induced pyroptosis in colon cancer through NEK7-mediated NLRP3 inflammasome-GSDMD signaling pathway activation. Am J Cancer Res. 14:934–958. 2024. View Article : Google Scholar : PubMed/NCBI
14	Krishnan SM, Ling YH, Huuskes BM, Ferens DM, Saini N, Chan CT, Diep H, Kett MM, Samuel CS, Kemp-Harper BK, et al: Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res. 115:776–787. 2019. View Article : Google Scholar :
15	Akther M, Haque ME, Park J, Kang TB and Lee KH: NLRP3 ubiquitination-A new approach to target NLRP3 inflammasome activation. Int J Mol Sci. 22:87802021. View Article : Google Scholar : PubMed/NCBI
16	Liu X, Fang Y, Lv X, Hu C, Chen G, Zhang L, Jin B, Huang L, Luo W, Liang G and Wang Y: Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death Differ. 30:1457–1471. 2023. View Article : Google Scholar : PubMed/NCBI
17	Xu T, Yu W, Fang H, Wang Z, Chi Z, Guo X, Jiang D, Zhang K, Chen S, Li M, et al: Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation. Cell Death Differ. 29:1582–1595. 2022. View Article : Google Scholar : PubMed/NCBI
18	Yan B, Jin Y, Mao S, Zhang Y, Yang D, Du M and Yin Y: Smurf2-mediated ubiquitination of FOXO4 regulates oxygen-glucose deprivation/reperfusion-induced pyroptosis of cortical neurons. Curr Neurovasc Res. 20:443–452. 2023. View Article : Google Scholar : PubMed/NCBI
19	Chaudhary KR, Kinslow CJ, Cheng H, Silva JM, Yu J, Wang TJ, Hei TK, Halmos B and Cheng SK: Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer. Sci Rep. 12:101402022. View Article : Google Scholar : PubMed/NCBI
20	Yang FR, Li SY, Hu XW, Li XR and Li HJ: Identifying the antitumor effects of curcumin on lung adenocarcinoma using comprehensive bioinformatics analysis. Drug Des Devel Ther. 16:2365–2382. 2022. View Article : Google Scholar : PubMed/NCBI
21	Schamberger B and Plaetzer K: Photofungizides based on curcumin and derivates thereof against candida albicans and aspergillus niger. Antibiotics (Basel). 10:13152021. View Article : Google Scholar : PubMed/NCBI
22	Galvao J, Davis B, Tilley M, Normando E, Duchen MR and Cordeiro MF: Unexpected low-dose toxicity of the universal solvent DMSO. FASEB J. 28:1317–1330. 2014. View Article : Google Scholar
23	Li M, Wu R, Wang L, Zhu D, Liu S, Wang R, Deng C, Zhang S, Chen M, Lu R, et al: Usenamine A triggers NLRP3/caspase-1/GSDMD-mediated pyroptosis in lung adenocarcinoma by targeting the DDX3X/SQSTM1 axis. Aging (Albany NY). 16:1663–1684. 2024. View Article : Google Scholar : PubMed/NCBI
24	Leng B, Zhang Y, Liu X, Zhang Z, Liu Y, Wang H and Lu M: Astragaloside IV suppresses high glucose-induced NLRP3 inflammasome activation by inhibiting TLR4/NF-κB and CaSR. Mediators Inflamm. 2019:10824972019. View Article : Google Scholar
25	Zhao C, Liang F, Ye M, Wu S, Qin Y, Zhao L, Zhang L, He J, Cen L and Lin F: GSDMD promotes neutrophil extracellular traps via mtDNA-cGAS-STING pathway during lung ischemia/reperfusion. Cell Death Discov. 9:3682023. View Article : Google Scholar : PubMed/NCBI
26	Ge X, Cai F, Shang Y, Chi F, Xiao H, Xu J, Fu Y and Bai C: PARK2 attenuates house dust mite-induced inflammatory reaction, pyroptosis and barrier dysfunction in BEAS-2B cells by ubiquitinating NLRP3. Am J Transl Res. 13:326–335. 2021.PubMed/NCBI
27	Zhang X, Zhang K and Zhang Y: Pigment epithelium-derived factor facilitates NLRP3 inflammasome activation through downregulating cytidine monophosphate kinase 2: A potential treatment strategy for missed abortion. Int J Mol Med. 45:1436–1446. 2020.PubMed/NCBI
28	Chen Z, Li P, Shen L and Jiang X: Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis. Oncol Rep. 50:1962023. View Article : Google Scholar : PubMed/NCBI
29	Shih KC, Chan HW, Wu CY and Chuang HY: Curcumin enhances the abscopal effect in mice with colorectal cancer by acting as an immunomodulator. Pharmaceutics. 15:15192023. View Article : Google Scholar : PubMed/NCBI
30	Kollias NS, Hess WJ, Johnson CL, Murphy M and Golab G: A literature review on current practices, knowledge, and viewpoints on pentobarbital euthanasia performed by veterinarians and animal remains disposal in the United States. J Am Vet Med Assoc. 261:733–738. 2023. View Article : Google Scholar : PubMed/NCBI
31	Cai B, Zhao J, Zhang Y, Liu Y, Ma C, Yi F, Zheng Y, Zhang L, Chen T, Liu H, et al: USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3. Autophagy. 18:990–1004. 2022. View Article : Google Scholar :
32	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
33	Calibasi-Kocal G, Pakdemirli A, Bayrak S, Ozupek NM, Sever T, Basbinar Y, Ellidokuz H and Yigitbasi T: Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer. J BUON. 24:1482–1487. 2019.PubMed/NCBI
34	Jing X, Yun Y, Ji X, Yang E and Li P: Pyroptosis and inflammasome-related genes-NLRP3, NLRC4 and NLRP7 polymorphisms were associated with risk of lung cancer. Pharmgenomics Pers Med. 16:795–804. 2023.PubMed/NCBI
35	Menon SS, Guruvayoorappan C, Sakthivel KM and Rasmi RR: Ki-67 protein as a tumour proliferation marker. Clin Chim Acta. 491:39–45. 2019. View Article : Google Scholar : PubMed/NCBI
36	Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR and Feuer EJ: The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 383:640–649. 2020. View Article : Google Scholar : PubMed/NCBI
37	Giordano A and Tommonaro G: Curcumin and cancer. Nutrients. 11:23762019. View Article : Google Scholar : PubMed/NCBI
38	Liu C, Rokavec M, Huang Z and Hermeking H: Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. Cell Death Differ. 30:1771–1785. 2023. View Article : Google Scholar : PubMed/NCBI
39	Luo T, Guan H, Liu J, Wang J and Zhang Y: Curcumin inhibits esophageal squamous cell carcinoma progression through down-regulating the circNRIP1/miR-532-3p/AKT pathway. Environ Toxicol. 38:2705–2716. 2023. View Article : Google Scholar : PubMed/NCBI
40	Fu J and Wu H: Structural Mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 41:301–316. 2023. View Article : Google Scholar : PubMed/NCBI
41	Zheng X, Wan J and Tan G: The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy. Front Immunol. 14:11511852023. View Article : Google Scholar : PubMed/NCBI
42	Yue E, Tuguzbaeva G, Chen X, Qin Y, Li A, Sun X, Dong C, Liu Y, Yu Y, Zahra SM, et al: Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma. Phytomedicine. 56:286–294. 2019. View Article : Google Scholar : PubMed/NCBI
43	Teng JF, Mei QB, Zhou XG, Tang Y, Xiong R, Qiu WQ, Pan R, Law BY, Wong VK, Yu CL, et al: Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer. Cancers (Basel). 12:1932020. View Article : Google Scholar
44	Wang X, Yin Y, Qian W, Peng C, Shen S, Wang T and Zhao S: Citric acid of ovarian cancer metabolite induces pyroptosis via the caspase-4/TXNIP-NLRP3-GSDMD pathway in ovarian cancer. FASEB J. 36:e223622022. View Article : Google Scholar : PubMed/NCBI
45	Xie W, Peng M, Liu Y, Zhang B, Yi L and Long Y: Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer. Cell Commun Signal. 21:3292023. View Article : Google Scholar : PubMed/NCBI
46	Liu X, Li M, Chen Z, Yu Y, Shi H, Yu Y, Wang Y, Chen R and Ge J: Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis. Basic Res Cardiol. 117:402022. View Article : Google Scholar : PubMed/NCBI
47	Chae DK, Park J, Cho M, Ban E, Jang M, Yoo YS, Kim EE, Baik JH and Song EJ: MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β receptor I ubiquitination. Mol Oncol. 13:2663–2678. 2019. View Article : Google Scholar : PubMed/NCBI
48	Han M, Guo Y, Li Y, Zeng Q, Zhu W and Jiang J: SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation. Int J Biol Sci. 19:3324–3340. 2023. View Article : Google Scholar : PubMed/NCBI
49	Pi Y, Feng Q, Sun F, Wang Z, Zhao Y, Chen D, Liu Y and Lou G: Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression. Cell Death Differ. 30:2382–2392. 2023. View Article : Google Scholar : PubMed/NCBI
50	Kong D, Zhang Z, Chen L, Huang W, Zhang F, Wang L, Wang Y, Cao P and Zheng S: Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy. Redox Biol. 36:1016002020. View Article : Google Scholar : PubMed/NCBI
51	Chen H, Yang R, Tang Y and Fu X: Effects of curcumin on artery blood gas index of rats with pulmonary fibrosis caused by paraquat poisoning and the expression of Smad 4, Smurf 2, interleukin-4 and interferon-γ. Exp Ther Med. 17:3664–3670. 2019.PubMed/NCBI